Sources

9 Total Sources

Eli Lilly Hits Record High on 19% Retatrutide Weight-Loss Data

Left50%

Center25%

Right25%

Eli Lilly Shares Hit All-Time Highs on Retatrutide Obesity Drug Data

tradingkey.com6h ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.37% on Jun 8: What Signal Does It Send?

FX Leaders22h ago

Eli Lilly Hits $1.01 Trillion Valuation as New Obesity Drug Data Reinforces GLP-1 Dominance - Forex News by FX Leaders

Stocktwits11h ago

LLY Stock Heads To Record High – Here's Why Retail's Bullish On Latest GLP-1 Data

The Wall Street Journal22h ago

Eli Lilly Stock Rises Premarket on Late-Stage Weight Loss Trial Success - WSJ

apexlaboratory.org19h ago

Retatrutide TRIUMPH-1: Phase 3 2026 Obesity Data Explained

U.S News & World Report Money22h ago

Lilly Shares Jump as Analysts See Retatrutide Data Extending Obesity Market Edge

TipRanks22h ago

Eli Lilly Stock (LLY) Jumps 4%. The Outlook for Its Weight-Loss Drugs Just Keeps Getting Better - TipRanks.com

Yahoo Finance22h ago

Why Did Solidion, Eli Lilly, Citigroup Stocks Hit 52-Week Highs Last Week?